$4.12
Today
as of Sep 4, 16:54 ET
Last 30 days
Recent Press Releases & News
SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026
SBC Medical Group Re-Accelerates Growth as EBITDA Surges 32% in Q2
Emerging Growth Research Issues Updated Press Release Announcing Company-Sponsored Research on SBC Medical Group Holdings Incorporated
Overview
52-week range
$2.78
$5.07
59% of range
Avg surprise (last 3)
+5.1%
Avg reaction (last 2)
-2.1%
50% positive
Latest IV / EM
585%
EM ±94.6% · $5 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.10 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $0.11 | $0.10 | +10.0% | -47.6% | -7.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.12 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $0.02 | $0.14 | -85.7% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $0.21 | $0.11 | +90.9% | — | +3.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.03 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.20 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.20 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.09 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $49M | $43M | — | $43M | $43M | $47M | — | $53M |
| Cost of revenue | $13M | $13M | — | $13M | $13M | $10M | — | $10M |
| Gross profit | $36M | $30M | — | $31M | $30M | $38M | — | $43M |
| Operating income | $19M | $18M | — | $16M | $15M | $24M | — | $14M |
| Net income | $11M | $11M | — | $13M | $2M | $21M | — | $3M |
| EPS (diluted) | $0.10 | $0.11 | — | $0.12 | $0.02 | $0.21 | — | $0.03 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $184M | $167M | $164M | $127M | $153M | $132M | $125M | $137M |
| Inventory | $3M | $2M | $3M | $2M | $2M | $2M | $1M | $2M |
| Total current assets | $259M | $239M | $231M | $227M | $241M | $215M | $184M | $202M |
| Total assets | $407M | $388M | $380M | $321M | $315M | $285M | $266M | $296M |
| Long-term debt | $38M | $40M | — | $21M | $7M | $7M | — | $823,153 |
| Total liabilities | $127M | $118M | $117M | $73M | $71M | $58M | $71M | $91M |
| Total equity | $264M | $270M | $248M | $248M | $245M | $226M | $195M | $206M |